Creative Planning Akebia Therapeutics, Inc. Transaction History
Creative Planning
- $101 Billion
- Q3 2024
A detailed history of Creative Planning transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 116,172 shares of AKBA stock, worth $204,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,172
Previous 110,690
4.95%
Holding current value
$204,462
Previous $112,000
36.61%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AKBA
# of Institutions
120Shares Held
54.8MCall Options Held
291KPut Options Held
179K-
Black Rock Inc. New York, NY11.6MShares$20.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$17.7 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$10.1 Million13.23% of portfolio
-
Geode Capital Management, LLC Boston, MA4.75MShares$8.37 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.72MShares$6.54 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $324M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...